NASHUA, N.H. (March 8, 2017) – iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced
image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer,
today reported financial results for the three and twelve months ended December 31, 2016.

View Webcast

Full Results